Methods of enhancing functioning of the large intestine

Details Methods of enhancing functioning of the large intestine Methods of enhancing functioning of the large intestine

2007-02-13

2007-02-13

Kam, Chih-Min (Department: 1656)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C530S308000, C530S324000, C530S344000, C435S366000, C424S009100

Reexamination Certificate

active

10419150

ABSTRACT:
The invention relates to glucagon-related peptides and their use for the prevention or treatment of disorders involving the large intestine. In particular, it has now been demonstrated that GLP-2 and peptidic agonists of GLP-2 can cause proliferation of the tissue of large intestine. Thus, the invention provides methods of proliferating the large intestine in a subject in need thereof. Further, the methods of the invention are useful to treat or prevent inflammatory conditions of the large intestine, including inflammatory bowel diseases.

REFERENCES:
patent: 5789379 (1998-08-01), Drucker et al.
patent: 5834428 (1998-11-01), Drucker et al.
patent: 6297214 (2001-10-01), Drucker et al.
patent: 6586399 (2003-07-01), Drucker

Affiliated with

Also associated with

Rating

Methods of enhancing functioning of the large intestine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of enhancing functioning of the large intestine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of enhancing functioning of the large intestine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3849653